<DOC>
	<DOCNO>NCT00831337</DOCNO>
	<brief_summary>This study evaluate role probiotic treatment portal hypertension . In particular role probiotic gut microbiota liver cirrhosis patient study compare cytokine substance implicate pathogenesis portal hypertension . The hypothesis whether probiotic may change prognosis patient portal hypertension study . The hypothesis whether probiotic may halt pathologic cascade event lead various complication ( e.g . hepato-renal syndrome , spontaneous bacterial peritonitis , bleed varix ) review .</brief_summary>
	<brief_title>Evaluation Probiotics Treatment Portal Hypertension</brief_title>
	<detailed_description>Studied probiotic : VSL3</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>Confirmed liver cirrhosis ( liver biopsy typical imaging study ) Confirmed portal hypertension 18 year old compliant patient Antibiotic treatment last 3 month Lactulose treatment last 3 month Patients take NSAIDS lat 3 month Steroid treatment last 3 month Ongoing active infection Pregnant woman Cancer diagnosis decompensated diabetes mellitus active past treatment recombinant cytokine ( e.g . anty TNF , interferon etc ) medication alter function CNS , suffer neurological ophthalmological condition initiate therapy beta blocker within prior 12 week mental disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>VSL3</keyword>
	<keyword>Probiotics</keyword>
	<keyword>Gut microbiota</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Portal hypertension</keyword>
	<keyword>Chemokines</keyword>
	<keyword>Liver cirrhosis</keyword>
</DOC>